← Eichor
Study identifier: NCT07573553 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Effectiveness of Rib Mobilization Combined With Postural Correction Exercises in Individuals With Upper Crossed Syndrome

Condition: Upper Cross Syndrome  ·  Sponsor: Riphah International University

PhaseNA
Planned participants64
Who can joinAll sexes, 20 Years to 45 Years
Healthy volunteersNo

About this study

This randomized controlled trial aims to evaluate the effectiveness of rib mobilization combined with postural correction exercises in reducing pain, improving cervical posture, and enhancing rib and thoracic mobility among individuals with Upper Crossed Syndrome (UCS). A total of 64 participants aged 20-45 years will be recruited and randomly assigned to two groups: Group A (rib mobilization + postural correction) and Group B (postural correction only). Intervention will be provided for 4-6 weeks, three sessions per week. Outcomes will include pain (VAS), cervical posture (inclinometer), and rib/thoracic mobility (tape measure). Data will be analyzed using SPSS version 26.

This description comes directly from the study's public registry record.

Talk to the study team

Altamash Hussain Khan, DPT  ·  +92 3088805119  ·  altamash.hussain1@icloud.com

Always discuss trial participation with your own doctor first.

Locations (1)

District Headquater HaripurChak Six Hundred Twenty-four, Khyber Pakhtunkhwat, PakistanRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07573553